TRPV1 may increase the effectiveness of estrogen therapy on neuroprotection and neuroregeneration

Ricardo Ramírez-Barrantes, Ivanny Marchant, Pablo Olivero

Resultado de la investigación: Review article

4 Citas (Scopus)

Resumen

Aging induces physical deterioration, loss of the blood brain barrier, neuronal loss-induced mental and neurodegenerative diseases. Hypotalamus-hypophysis-gonad axis aging precedes symptoms of menopause or andropause and is a major determinant of sensory and cognitive integrated function. Sexual steroids support important functions, exert pleiotropic effects in different sensory cells, promote regeneration, plasticity and health of the nervous system. Their diminution is associated with impaired cognitive and mental health and increased risk of neurodegenerative diseases. Then, restoring neuroendocrine axes during aging can be key to enhance brain health through neuroprotection and neuroregeneration, depending on the modulation of plasticity mechanisms. Estrogen-dependent transient receptor potential cation channel, subfamily V, member 1 (TRPV1) expression induces neuroprotection, neurogenesis and regeneration on damaged tissues. Agonists of TRPV1 can modulate neuroprotection and repair of sensitive neurons, while modulators as other cognitive enhancers may improve the survival rate, differentiation and integration of neural stem cell progenitors in functional neural network. Menopause constitutes a relevant clinical model of steroidal production decline associated with progressive cognitive and mental impairment, which allows exploring the effects of hormone therapy in health outcomes such as dysfunction of CNS. Simulating the administration of hormone therapy to virtual menopausal individuals allows assessing its hypothetical impact and sensitivity to conditions that modify the effectiveness and efficiency.

Idioma originalEnglish
Páginas (desde-hasta)1204-1207
Número de páginas4
PublicaciónNeural Regeneration Research
Volumen11
N.º8
DOI
EstadoPublished - ago 2016

Huella dactilar

Estrogens
Menopause
Neurodegenerative Diseases
Regeneration
Health
Andropause
Hormones
Nootropic Agents
Transient Receptor Potential Channels
Neural Stem Cells
Neurogenesis
Gonads
Pituitary Gland
Blood-Brain Barrier
Cognition
Nervous System
Mental Health
Therapeutics
Steroids
Neurons

ASJC Scopus subject areas

  • Developmental Neuroscience

Citar esto

@article{890193e033d14018ad188af68b7349c7,
title = "TRPV1 may increase the effectiveness of estrogen therapy on neuroprotection and neuroregeneration",
abstract = "Aging induces physical deterioration, loss of the blood brain barrier, neuronal loss-induced mental and neurodegenerative diseases. Hypotalamus-hypophysis-gonad axis aging precedes symptoms of menopause or andropause and is a major determinant of sensory and cognitive integrated function. Sexual steroids support important functions, exert pleiotropic effects in different sensory cells, promote regeneration, plasticity and health of the nervous system. Their diminution is associated with impaired cognitive and mental health and increased risk of neurodegenerative diseases. Then, restoring neuroendocrine axes during aging can be key to enhance brain health through neuroprotection and neuroregeneration, depending on the modulation of plasticity mechanisms. Estrogen-dependent transient receptor potential cation channel, subfamily V, member 1 (TRPV1) expression induces neuroprotection, neurogenesis and regeneration on damaged tissues. Agonists of TRPV1 can modulate neuroprotection and repair of sensitive neurons, while modulators as other cognitive enhancers may improve the survival rate, differentiation and integration of neural stem cell progenitors in functional neural network. Menopause constitutes a relevant clinical model of steroidal production decline associated with progressive cognitive and mental impairment, which allows exploring the effects of hormone therapy in health outcomes such as dysfunction of CNS. Simulating the administration of hormone therapy to virtual menopausal individuals allows assessing its hypothetical impact and sensitivity to conditions that modify the effectiveness and efficiency.",
keywords = "Aging, Estrogen, Hormonal replacent, Neuroprotection, TRPV1",
author = "Ricardo Ram{\'i}rez-Barrantes and Ivanny Marchant and Pablo Olivero",
year = "2016",
month = "8",
doi = "10.4103/1673-5374.189162",
language = "English",
volume = "11",
pages = "1204--1207",
journal = "Neural Regeneration Research",
issn = "1673-5374",
publisher = "Editorial Board of Neural Regeneration Research",
number = "8",

}

TRPV1 may increase the effectiveness of estrogen therapy on neuroprotection and neuroregeneration. / Ramírez-Barrantes, Ricardo; Marchant, Ivanny; Olivero, Pablo.

En: Neural Regeneration Research, Vol. 11, N.º 8, 08.2016, p. 1204-1207.

Resultado de la investigación: Review article

TY - JOUR

T1 - TRPV1 may increase the effectiveness of estrogen therapy on neuroprotection and neuroregeneration

AU - Ramírez-Barrantes, Ricardo

AU - Marchant, Ivanny

AU - Olivero, Pablo

PY - 2016/8

Y1 - 2016/8

N2 - Aging induces physical deterioration, loss of the blood brain barrier, neuronal loss-induced mental and neurodegenerative diseases. Hypotalamus-hypophysis-gonad axis aging precedes symptoms of menopause or andropause and is a major determinant of sensory and cognitive integrated function. Sexual steroids support important functions, exert pleiotropic effects in different sensory cells, promote regeneration, plasticity and health of the nervous system. Their diminution is associated with impaired cognitive and mental health and increased risk of neurodegenerative diseases. Then, restoring neuroendocrine axes during aging can be key to enhance brain health through neuroprotection and neuroregeneration, depending on the modulation of plasticity mechanisms. Estrogen-dependent transient receptor potential cation channel, subfamily V, member 1 (TRPV1) expression induces neuroprotection, neurogenesis and regeneration on damaged tissues. Agonists of TRPV1 can modulate neuroprotection and repair of sensitive neurons, while modulators as other cognitive enhancers may improve the survival rate, differentiation and integration of neural stem cell progenitors in functional neural network. Menopause constitutes a relevant clinical model of steroidal production decline associated with progressive cognitive and mental impairment, which allows exploring the effects of hormone therapy in health outcomes such as dysfunction of CNS. Simulating the administration of hormone therapy to virtual menopausal individuals allows assessing its hypothetical impact and sensitivity to conditions that modify the effectiveness and efficiency.

AB - Aging induces physical deterioration, loss of the blood brain barrier, neuronal loss-induced mental and neurodegenerative diseases. Hypotalamus-hypophysis-gonad axis aging precedes symptoms of menopause or andropause and is a major determinant of sensory and cognitive integrated function. Sexual steroids support important functions, exert pleiotropic effects in different sensory cells, promote regeneration, plasticity and health of the nervous system. Their diminution is associated with impaired cognitive and mental health and increased risk of neurodegenerative diseases. Then, restoring neuroendocrine axes during aging can be key to enhance brain health through neuroprotection and neuroregeneration, depending on the modulation of plasticity mechanisms. Estrogen-dependent transient receptor potential cation channel, subfamily V, member 1 (TRPV1) expression induces neuroprotection, neurogenesis and regeneration on damaged tissues. Agonists of TRPV1 can modulate neuroprotection and repair of sensitive neurons, while modulators as other cognitive enhancers may improve the survival rate, differentiation and integration of neural stem cell progenitors in functional neural network. Menopause constitutes a relevant clinical model of steroidal production decline associated with progressive cognitive and mental impairment, which allows exploring the effects of hormone therapy in health outcomes such as dysfunction of CNS. Simulating the administration of hormone therapy to virtual menopausal individuals allows assessing its hypothetical impact and sensitivity to conditions that modify the effectiveness and efficiency.

KW - Aging

KW - Estrogen

KW - Hormonal replacent

KW - Neuroprotection

KW - TRPV1

UR - http://www.scopus.com/inward/record.url?scp=84988855161&partnerID=8YFLogxK

U2 - 10.4103/1673-5374.189162

DO - 10.4103/1673-5374.189162

M3 - Review article

AN - SCOPUS:84988855161

VL - 11

SP - 1204

EP - 1207

JO - Neural Regeneration Research

JF - Neural Regeneration Research

SN - 1673-5374

IS - 8

ER -